Britannia Life Sciences Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BLAB.CN research report →
Companybritannia.life
Britannia Life Sciences Inc. provides product testing, safety assessment, and compliance services to the cosmetics, nutraceutical, and consumer packaged goods industries in the United Kingdom and internationally. The company is based in Toronto, Canada.
- CEO
- Peter James Shippen
- IPO
- 2021
- Employees
- 28
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $13.79M
- P/E
- 0.67
- P/S
- -3.18
- P/B
- 0.80
- EV/EBITDA
- -2.46
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 69.53%
- Op Margin
- 73.26%
- Net Margin
- -472.89%
- ROE
- 240.12%
- ROIC
- -15.00%
Growth & Income
- Revenue
- $369.28K · -95.12%
- Net Income
- $7.39M · 255.06%
- EPS
- $-0.03 · 2.04%
- Op Income
- $-2,249,945
- FCF YoY
- -249.33%
Performance & Tape
- 52W High
- $0.14
- 52W Low
- $0.06
- 50D MA
- $0.09
- 200D MA
- $0.09
- Beta
- -0.07
- Avg Volume
- 112.50K
Get TickerSpark's AI analysis on BLAB.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BLAB.CN Coverage
We haven't published any research on BLAB.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BLAB.CN Report →